Alliance Discussion with Dr. Jeffrey Cummings, University of Nevada

As the debate over coverage for new Alzheimer’s drugs continues, we’ve asked Dr. Jeffrey Cummings of the University of Nevada, Las Vegas to discuss the challenging path that led to these medicines, the state of the science now, and hope for the future. More than 6.7 million individuals in the U.S. have Alzheimer’s disease, and that number is growing rapidly. Each day that passes without effective treatments brings tragic consequences for patients and their loved ones. Please join us for this important conversation.